PRAXIS PRECISION MEDICINES, INC. Operating Lease Liability
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Operating Lease Liability of $1.40 million as of 2026-03-01, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-03-01: Operating Lease, Liability $1.40M.
- 2025-12-31: Operating Lease, Liability $110.00K.
- 2024-12-31: Operating Lease, Liability $1.37M.
- 2023-12-31: Operating Lease, Liability $2.50M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-03-01 | $1.40M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $110.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $1.37M 10-K · filed 2026-02-19 |
| 2023-12-31 | $2.50M 10-K · filed 2025-02-28 |
| 2022-12-31 | $3.50M 10-K · filed 2024-03-05 |
| 2021-12-31 | $4.31M 10-K · filed 2023-02-07 |
| 2021-10-01 | $4.10M 10-K · filed 2023-02-07 |
| 2021-09-30 | $4.21M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $4.12M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $763.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |